Myomo (MYO) EBITDA (2016 - 2025)

Myomo (MYO) has reported EBITDA for 10 consecutive years, with -$3.5 million the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, EBITDA fell 267.34% year-over-year to -$3.5 million; the trailing twelve-month figure through Sep 2025 stood at -$11.9 million (down 41.44% YoY), and the FY2024 full-year result was -$6.2 million, up 24.6% from the prior year.
• EBITDA climbed to -$3.5 million in Q3 2025 per MYO's latest filing, from -$4.6 million in the prior quarter.
• Across five years, EBITDA topped out at -$245314.0 in Q4 2024 and bottomed at -$4.6 million in Q2 2025.
• Historically, EBITDA has averaged -$2.5 million across 5 years, with a median of -$2.7 million in 2023.
• The sharpest annual moves came in 2024 and 2025: EBITDA soared 89.92% in 2024, then tumbled 311.66% in 2025.
• Over 5 years, EBITDA stood at -$2.7 million in 2021, then gained by 17.61% to -$2.2 million in 2022, then retreated by 9.14% to -$2.4 million in 2023, then jumped by 89.92% to -$245314.0 in 2024, then slumped by 1333.88% to -$3.5 million in 2025.
• According to Business Quant data, EBITDA over the past three periods registered -$3.5 million, -$4.6 million, and -$3.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.